Activated protein C resistance testing for factor V Leiden.

作者: Stephan Kadauke , Bernard Khor , Elizabeth M. Van Cott

DOI: 10.1002/AJH.23867

关键词:

摘要: Activated protein C resistance assays can detect factor V Leiden with high accuracy, depending on the method used. Factor Xa inhibitors such as rivaroxaban and direct thrombin including dabigatran, argatroban, bivalirudin cause falsely normal results. Lupus anticoagulants incorrect results in most current assays. Assays that include dilution into V-deficient plasma are needed to avoid interference from deficiencies or elevations, which arise a wide variety of conditions warfarin, liver dysfunction, pregnancy. The pros cons currently available discussed.

参考文章(38)
Hans de Ronde, Rogier M Bertina, Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria Thrombosis and Haemostasis. ,vol. 72, pp. 880- 886 ,(1994) , 10.1055/S-0038-1648978
K V Voelkerding, S Huber, E C Williams, S Hoffman, F J Strobl, Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma. Archives of Pathology & Laboratory Medicine. ,vol. 122, pp. 430- 433 ,(1998)
Frits Rosendaal, Marco Cattaneo, Maurizio Margaglione, Valerio De Stefano, Tony Cumming, Valder Arruda, Andreas Hillarp, Jean-Luc Reny, Joseph Emmerich, , Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls Thrombosis and Haemostasis. ,vol. 86, pp. 809- 816 ,(2001) , 10.1055/S-0037-1616136
A. HILLARP, F. BAGHAEI, I. FAGERBERG BLIXTER, K. M. GUSTAFSSON, L. STIGENDAL, M. STEN-LINDER, K. STRANDBERG, T. L. LINDAHL, Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. Journal of Thrombosis and Haemostasis. ,vol. 9, pp. 133- 139 ,(2011) , 10.1111/J.1538-7836.2010.04098.X
Andreas Calatzis, Beatrice Bühler, Brigitte Conell, Marianne Wilmer, Christoph Stocker, Improved Distinction of Factor V Wild-Type and Factor V Leiden Using a Novel Prothrombin-Based Activated Protein C Resistance Assay American Journal of Clinical Pathology. ,vol. 122, pp. 836- 842 ,(2004) , 10.1309/T8AV-VH7Q-WGL0-QTF5
Kenneth Segers, Björn Dahlbäck, Gerry Nicolaes, Coagulation factor V and thrombophilia: Background and mechanisms Thrombosis and Haemostasis. ,vol. 98, pp. 530- 542 ,(2007) , 10.1160/TH07-02-0150
Elizabeth M. Van Cott, All that glitters is gold American Journal of Hematology. ,vol. 85, pp. 223- 224 ,(2010) , 10.1002/AJH.21641
Ariella Zivelin, Ronit Mor-Cohen, Victoria Kovalsky, Nurit Kornbrot, Jacqueline Conard, Flora Peyvandi, Paul A. Kyrle, Rogier Bertina, Ferial Peyvandi, Joseph Emmerich, Uri Seligsohn, Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago Blood. ,vol. 107, pp. 4666- 4668 ,(2006) , 10.1182/BLOOD-2005-12-5158
Peter Quehenberger, Sylvia Handler, Christine Mannhalter, Paul Alexander Kyrle, Wolfgang Speiser, The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation. Thrombosis Research. ,vol. 96, pp. 125- 133 ,(1999) , 10.1016/S0049-3848(99)00090-0
Marie Hacquard, Yveline Alnot, Emmanuel de Maistre, Thomas Lecompte, Elisabeth André, Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk? Thrombosis and Haemostasis. ,vol. 98, pp. 693- 694 ,(2007) , 10.1160/TH06-11-0661